免疫チェックポイント阻害剤治療後の無症状のトロポニン上昇と早期死亡率
Yuma Shibutani1, Takuro Imaoka2, Atsuko Suzuki3
1Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan.
Cancer diagnosis & prognosis
|September 3, 2025
まとめ
免疫チェックポイント阻害剤 (ICI) を服用している患者では,サブ臨床的トロポニン値上昇は一般的です. トロポニンのレベルが高いことは,早期の癌進行死亡率を示し,その予後的意義に関するさらなる調査を正当化します.
科学分野:
- 心臓病科
- 腫瘍学
- 免疫学
背景:
- 免疫チェックポイント阻害剤 (ICI) は有効ながん治療法ですが,心血管の有害事象を引き起こす可能性があります.
- 筋膜炎は既知の合併症ですが,無症状のトロポニン値上昇がますます観察されています.
- これらの亜臨床的トロポニン値上昇の予後効果は十分に理解されていません.
研究 の 目的:
- ICIで治療された患者における無症状のトロポニン上昇と早期死亡率との関係を調査する.
- ICIを投与する患者におけるサブ臨床的トロポニン上昇の頻度を評価する.
- トロポニン濃度と癌の進行との関連性を調べる
主な方法:
- ICIで治療された108人の患者で,単一センターでの遡及研究.
- 高感度トロポニンT (hs-TnT) の測定は,治療開始時と治療後の測定である.
- hs- TnT上昇による分類.
主要な成果:
- 24. 1% の患者 (26/ 108) がICI後のhs- TnT上昇を示し,臨床的な心臓イベントはなかった.
- hs- TnTのピーク値は,上昇したグループで有意に高かった (28 ng/ l vs.
- トロポニン濃度の上昇は,追跡期間中の早期がん進行による死亡率と相関していた.
結論:
- ICI治療を受けている患者では,サブ臨床的なトロポニン上昇が頻繁に見られる.
- トロポニンの上昇は早期の癌死亡率と関連している可能性があるが,そのメカニズムは不明である.
- これらの発見の予後値を確立するためにさらなる研究が必要である.
関連する概念動画
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Acute Coronary Syndrome I: Introduction
71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Myocarditis IV: Nursing Management
26
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
26


